Codexis Inc - Company Profile
Powered by 
All the data and insights you need on Codexis Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Codexis Inc Strategy Report
- Understand Codexis Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Codexis Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Codexis Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Byron L. Dorgan
Chairman Executive BoardMr. Byron L. Dorgan has been the Chairman of the company since 2021. Previously, he served as the Representative of the State of North Dakota from 1992 to January 2011. Prior to this, Mr. Dorgan served in the United States House of Representatives from 1981 to 1992 and as a member of the United States Senate, he held various roles, including Assistant Democratic Floor Leader; Chairman of the Democratic Policy Committee; Chairman of the Committee on Indian Affairs and Senior Senator on the Appropriations, Energy and Commerce Committees. Prior to this role, he was the State Tax Commissioner of North Dakota from 1969 to 1980.
Stephen Dilly
President; Director; Chief Executive Officer Executive BoardMr. Stephen Dilly has been the President, Director and Chief Executive Officer of the company since 2022. Prior to this, he served as a Chief Executive Officer at Sierra Oncology, Inc. Previously, he served as the Chief Executive Officer of Aimmune Therapeutics. He also served in various executive roles at Genentech, Chiron and SmithKline Beecham.
Sri Ryali
Chief Financial Officer Senior ManagementMr. Sri Ryali has been the Chief Financial Officer of the company since January 2023. Previously, he served as the Chief Financial Officer of Eiger BioPharmaceuticals, Inc. He also served as the Vice President, Finance and Senior Director, Finance at Aimmune Therapeutics, Inc.
Kevin Norrett
Chief Operating Officer Senior ManagementMr. Kevin Norrett has been the Chief Operating Officer of the company since October 2022. Prior to this he served as a Chief Business Officer of Sierra Oncology, Inc. Prior to this he served as a Chief Commercial Officer at Angion Biomedica Corp, Vice President of Marketing, Market Access and Commercial Operations at Aimmune Therapeutics, Vice President, Market Access and Commercial Development at ZS Pharma, Inc.
Margaret Fitzgerald
General Counsel; Secretary; Chief Legal and Compliance Officer Senior ManagementMs. Margaret Fitzgerald has been the Chief Legal and Compliance Officer, Secretary and General Counsel of the company November 2022. Prior to this, she served as the General Counsel, Corporate Secretary and Chief Compliance Officer at Allakos, Inc. Previously, she served as the Associate General Counsel and Privacy Officer at Aimmune Therapeutics, Inc. Before that, she served as Vice President of Corporate Law at ZS Pharma, Inc.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer